Live Breaking News & Updates on Late Breaking Clinical Trialsoral Presentation

Travere Therapeutics (TVTX) Announces Data Presentations of Interim Analysis from Phase 3 PROTECT Study of FILSPARI
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Krung Thep Mahanakhon , Naomi Eichenbaumvice , Nivi Nehravice , Travere Therapeutics Inc , Exchange Commission , Corporate Communications , World Congress , European Union , Company Annual Report On Form , Bits Association , Wall Street , Clinical Meetings , Dual Endothelin Angiotensin Receptor Antagonist , Reduces Proteinuria , Interim Results , Late Breaking Clinical Trialsoral Presentation , Plenary Hall , Patient Baseline Characteristics , Asian Regions , Young Patients , Label Extensionposter , Sustained Proteinuria Reduction , Interim Resultslate Breaking , Sparsentan Treatment , Label Extension ,